252 related articles for article (PubMed ID: 16476686)
1. Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.
Thomas T; Thomas K; Sadrieh N; Savage N; Adair P; Bronaugh R
Toxicol Sci; 2006 May; 91(1):14-9. PubMed ID: 16476686
[TBL] [Abstract][Full Text] [Related]
2. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
Thomas K; Sayre P
Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
[TBL] [Abstract][Full Text] [Related]
3. Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
Thomas K; Aguar P; Kawasaki H; Morris J; Nakanishi J; Savage N
Toxicol Sci; 2006 Jul; 92(1):23-32. PubMed ID: 16687392
[TBL] [Abstract][Full Text] [Related]
4. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
[TBL] [Abstract][Full Text] [Related]
5. Safety assessment of personal care products/cosmetics and their ingredients.
Nohynek GJ; Antignac E; Re T; Toutain H
Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
[TBL] [Abstract][Full Text] [Related]
6. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
7. Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.
Thomas T; Bahadori T; Savage N; Thomas K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):426-33. PubMed ID: 20049808
[TBL] [Abstract][Full Text] [Related]
8. Potential exposure of German consumers to engineered nanoparticles in cosmetics and personal care products.
Lorenz C; Von Goetz N; Scheringer M; Wormuth M; Hungerbühler K
Nanotoxicology; 2011 Mar; 5(1):12-29. PubMed ID: 21417685
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of oral exposure to diisononyl phthalate from children's products.
Babich MA; Chen SB; Greene MA; Kiss CT; Porter WK; Smith TP; Wind ML; Zamula WW
Regul Toxicol Pharmacol; 2004 Oct; 40(2):151-67. PubMed ID: 15450718
[TBL] [Abstract][Full Text] [Related]
10. Human exposure to phthalates via consumer products.
Schettler T
Int J Androl; 2006 Feb; 29(1):134-9; discussion 181-5. PubMed ID: 16466533
[TBL] [Abstract][Full Text] [Related]
11. Analytical methods to assess nanoparticle toxicity.
Marquis BJ; Love SA; Braun KL; Haynes CL
Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology safety concerns revisited.
Stern ST; McNeil SE
Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
[TBL] [Abstract][Full Text] [Related]
13. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
[TBL] [Abstract][Full Text] [Related]
14. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
Fairbrother A; Fairbrother JR
Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
[TBL] [Abstract][Full Text] [Related]
15. Naturally occurring asbestos: a recurring public policy challenge.
Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology and the Nanodermatology Society.
Nasir A; Friedman A
J Drugs Dermatol; 2010 Jul; 9(7):879-82. PubMed ID: 20677548
[TBL] [Abstract][Full Text] [Related]
17. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
18. Survey of organosilicone compounds, including cyclic and linear siloxanes, in personal-care and household products.
Horii Y; Kannan K
Arch Environ Contam Toxicol; 2008 Nov; 55(4):701-10. PubMed ID: 18443842
[TBL] [Abstract][Full Text] [Related]
19. Research strategies for safety evaluation of nanomaterials, Part III: nanoscale technologies for assessing risk and improving public health.
Balshaw DM; Philbert M; Suk WA
Toxicol Sci; 2005 Dec; 88(2):298-306. PubMed ID: 16162851
[TBL] [Abstract][Full Text] [Related]
20. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
